ASA: Antiplatelet Tops Aspirin for Secondary Stroke Prevention

Medpage Today -- SAN ANTONIO -- Cilostazol, an antiplatelet agent used in the U.S. to treat intermittent claudication, was better than aspirin at preventing recurrent stroke from noncardiogenic sources, a randomized trial conducted in Japan showed.